<?xml version="1.0" encoding="UTF-8"?>
<ref id="R11">
 <label>11</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Lai</surname>
    <given-names>C-C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Shih</surname>
    <given-names>T-P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ko</surname>
    <given-names>W-C</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges</article-title>. 
  <source>Int J Antimicrob Agents</source>
  <year>2020</year>;
  <volume>55</volume>:
  <elocation-id>105924</elocation-id>. 
  <pub-id pub-id-type="doi">10.1016/j.ijantimicag.2020.105924</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/32081636?>
  <pub-id pub-id-type="pmid">32081636</pub-id>
 </mixed-citation>
</ref>
